Summary
Two immunoassays for apolipoproteins AI and B were evaluated in 5 European laboratories. The assays are based on the immunoturbidimetric detection of the precipitin reaction between apolipoproteins and specific anti-apolipoprotein antibodies at 340 nm. The measurements with the new reagents were performed on BM/Hitachi 704/717 and COBAS® Mira analysers. In method comparison with automated routine assays, a reasonable comparability was obtained with apo AI, whereas larger discrepancies were found with some of the routine procedures for apo B. The results indicate that the new reagents can be successfully integrated into standard lipid diagnostics performed on clinical chemistry analysers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adolphson JL, Albers JJ (1989) Comparison of two commercial nephelometric methods for apoprotein AI and apoprotein B with standardized apoprotein AI and B radioimmunoassays. J Lipid Res 30: 597–606
Bachorik Ps, Kwiterovich Jr PO (1989) Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays. Clin Chim Acta 178: 1–34
Glick MR, Ryder KW, Jackson SA (1986) Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 32 (3): 470–475
Karl J, Kerscher L, Engel WD, Ziegenhorn J (1989) Immunoturbidimetric determination of apolipoprotein AI and B on Hitachi analyzers. (Abstr.) Clin Chem 35 /6: 1067
Labeur C, Shepherd J, Rosseneu M (1990) Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem 36 (4): 591–597
Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AB, Dinh DM, Mao SJT (1983) Apolipoprotein AI as a marker of angiographically assessed coronary artery disease. N Engl J Med 309: 385–389
Maciejko JJ, Levinson SS, Markyvech L, Smith MP, Blevins RD (1987) New assay of apolipoproteins AI and B by rate nephelometry evaluated. Clin Chem 33 (11): 2065–2069
Naito HK (1986) Serum apolipoprotein measurements: an improved discriminator for assessing coronary heart disease. Compr Ther 13 (1): 43–52
Riesen WF, Mordasini R, Salzman C, Theler A, Gurtner HP (1980) Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis 37: 157–162
Smith SJ, Cooper GR, Henderson LO, Hannon WH, Apolipoprotein Standardization Collaborating Group (1978) An international collaborative study on standardization of apolipoproteins AI and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem 33: 2240–2249
Smith SJ, Cooper GR, Henderson LO, Hannon WH, Phase V (1987) Preliminary report. Apolipoprotein standardization program IUISCDC-NHLBI, December 1987
Wang XL, Dudman NPB, Blades BL, Wicken DEL (1989) Changes in the immunoreactivity of apo a-I during storage. Clin Chim Acta 179: 285–294
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag/Wien
About this chapter
Cite this chapter
Jarausch, J. et al. (1991). Results from a European multicentre evaluation of immunoturbidimetric assays for apolipoproteins AI and B. In: Rosseneu, M., Widhalm, K., Jarausch, J. (eds) Apolipoproteins in Lipid Disorders. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9148-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9148-4_8
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82273-9
Online ISBN: 978-3-7091-9148-4
eBook Packages: Springer Book Archive